Biogen Inc.
US ˙ NasdaqGS ˙ US09062X1037

SecurityBIIB / Biogen Inc.
InstitutionFox Run Management, L.l.c.
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Fox Run Management, L.l.c. closes position in BIIB / Biogen Inc.

On February 11, 2026 - Fox Run Management, L.l.c. filed a 13F-HR form disclosing ownership of 0 shares of Biogen Inc. (US:BIIB) valued at $0 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 12, 2025 disclosing 6,969 shares of Biogen Inc.. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-11 2025-12-31 13F BIOGEN COM 09062X103 0 -100.00 0
2025-11-12 2025-09-30 13F BIOGEN COM 09062X103 6,969 -5,922 -45.94 976 -39.68 0.1522
2025-08-06 2025-06-30 13F BIOGEN COM 09062X103 12,891 3,777 41.44 1,619 29.75 0.2697
2025-05-13 2025-03-31 13F BIOGEN COM 09062X103 9,114 9,114 1,247 0.1932
2025-02-11 2024-12-31 13F BIOGEN COM 09062X103 0 -7,922 -100.00 0 -100.00
2024-11-12 2024-09-30 13F BIOGEN COM 09062X103 7,922 7,922 1,536 0.3417
2024-08-13 2024-06-30 13F BIOGEN COM 09062X103 0 -1,974 -100.00 0 -100.00
2024-05-13 2024-03-31 13F BIOGEN COM 09062X103 1,974 1,974 426 0.0918
2023-11-07 2023-09-30 13F BIOGEN COM 09062X103 0 -2,380 -100.00 0 -100.00
2023-08-11 2023-06-30 13F BIOGEN COM 09062X103 2,380 2,380 678 0.1907
2023-05-12 2023-03-31 13F BIOGEN COM 09062X103 0 -1,854 -100.00 0 -100.00
2023-02-07 2022-12-31 13F BIOGEN COM 09062X103 1,854 1,854 513 0.2061
2022-11-07 2022-09-30 13F BIOGEN COM 09062X103 0 -2,862 -100.00 0 -100.00
2022-08-12 2022-06-30 13F BIOGEN COM 09062X103 2,862 1,255 78.10 584 72.78 0.2915
2022-05-10 2022-03-31 13F BIOGEN COM 09062X103 1,607 1,607 338 0.1882
2022-02-09 2021-12-31 13F BIOGEN COM 09062X103 0 -707 -100.00 0 -100.00
2021-11-15 2021-09-30 13F BIOGEN COM 09062X103 707 707 200 0.1260
2020-02-14 2019-12-31 13F BIOGEN COM 09062X103 0 -2,394 -100.00 0 -100.00
2019-10-15 2019-09-30 13F/A-1 BIOGEN COM 09062X103 2,394 203 9.27 557 8.79 0.5070
2019-10-11 2019-09-30 13F BIOGEN COM 09062X103 2,191 0 512
2019-07-17 2019-06-30 13F BIOGEN COM 09062X103 2,191 -79 -3.48 512 -4.66 0.3400
2019-10-17 2019-03-31 13F BIOGEN COM 09062X103 2,270 1,005 79.45 537 40.94 0.3034
2019-01-15 2018-12-31 13F BIOGEN COM 09062X103 1,265 1,265 381 0.2019
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.